CureVac
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CureVac and buy or sell other stocks, ETFs, and their options commission-free!About CVAC
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy.
CEOAlexander Zehnder, MD, MBA
CEOAlexander Zehnder, MD, MBA
Employees983
Employees983
HeadquartersTübingen, Baden Wuerttemberg
HeadquartersTübingen, Baden Wuerttemberg
Founded2020
Founded2020
Employees983
Employees983
CVAC Key Statistics
Market cap1.05B
Market cap1.05B
Price-Earnings ratio6.48
Price-Earnings ratio6.48
Dividend yield—
Dividend yield—
Average volume511.36K
Average volume511.36K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.72
52 Week high$5.72
52 Week low$2.48
52 Week low$2.48
Stock Snapshot
The current CureVac(CVAC) stock price is $4.66, with a market capitalization of 1.05B. The stock trades at a price-to-earnings (P/E) ratio of 6.48.
On 2026-01-14, CureVac(CVAC) stock opened at —, reached a high of —, and a low of —.
CureVac(CVAC) shares are trading with a volume of 0, against a daily average of 511.36K.
In the last year, CureVac(CVAC) shares hit a 52-week high of $5.72 and a 52-week low of $2.48.
In the last year, CureVac(CVAC) shares hit a 52-week high of $5.72 and a 52-week low of $2.48.
People also own
Based on the portfolios of people who own CVAC. This list is generated using Robinhood data, and it’s not a recommendation.